B Cell Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Not yet recruiting
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-12-02
Dec 2, 2021
N
Recruiting
  • T-cell Lymphoma
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-12-02
    Dec 2, 2021
    E
    Recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • +6 more
    • Miami, Florida
    • +2 more
    2021-11-19
    Nov 19, 2021
    M
    Recruiting
    • B Cell ALL
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    2021-11-16
    Nov 16, 2021
    N
    Recruiting
    • Acute Lymphoid Leukemia
    • +4 more
    • CD19/CD22 CAR T-Cells
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-11-16
    Nov 16, 2021
    T
    Recruiting
    • B-Cell Lymphoma
    • Heidelberg, Victoria, Australia
    • +2 more
    2021-11-11
    Nov 11, 2021
    N
    Recruiting
    • B-cell Lymphoma
    • +8 more
    • Polatuzumab vedotin
    • Valhalla, New York
      New York Medical Center
    2021-10-29
    Oct 29, 2021
    B
    Completed
    • B-cell Lymphoma
    • Beijing, Beijing, China
    • +3 more
    2021-09-26
    Sep 26, 2021
    U
    Completed
    • B-cell Leukemia
    • B-Cell Lymphoma
    • CAR T cells
    • Uppsala, Sweden
      Uppsala University Hospital, Dept of Oncology
    2021-10-14
    Oct 14, 2021
    D
    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Boston, Massachusetts
    • +1 more
    2021-10-19
    Oct 19, 2021
    C
    Recruiting
    • B-cell Malignancy
    • +3 more
    • CTX110
    • Los Angeles, California
    • +22 more
    2021-10-05
    Oct 5, 2021
    B
    Recruiting
    • B-cell Lymphoma
    • CD19-Specific Chimeric Antigen Receptor T cells with PD1 knockout
    • Hangzhou, Zhejiang, China
      the First Affliated Hospital, Zhejiang University
    2021-09-23
    Sep 23, 2021
    L
    Recruiting
    • Chronic Lymphocytic Leukemia
    • +5 more
    • Scottsdale, Arizona
    • +55 more
    2021-09-17
    Sep 17, 2021
    P
    Not yet recruiting
    • B-cell Lymphoma
    • (no location specified)
    2021-08-23
    Aug 23, 2021
    9
    Recruiting
    • B-cell Lymphoma
    • CTA30X UCAR-T injection
    • Kunming, Yunnan, China
      No.212 Daguan Road, Xishan District
    2021-08-15
    Aug 15, 2021
    V
    Withdrawn
    • B-cell Lymphoma
    • Covid19
      • (no location specified)
      2021-08-13
      Aug 13, 2021
      K
      Active, not recruiting
      • B-cell Lymphoma
      • Axicabtagene Ciloleucel
      • +2 more
      • Gilbert, Arizona
      • +11 more
      2021-08-16
      Aug 16, 2021
      Z
      Suspended
      • B-Cell Leukemia
      • B-Cell Lymphoma
      • Guangzhou, Guangdong, China
        Zhujiang Hospital of Southern Medical University
      2021-08-09
      Aug 9, 2021
      G
      Recruiting
      • B-cell Lymphoma
      • LP-168 tablet
      • Beijing, Beijing, China
        Jun Zhu
      2021-08-08
      Aug 8, 2021